Understanding how T cells can resist exhaustion during chronic viral infections
Resistance to T cell exhaustion
This study is looking at how certain immune cells called CD8 T cells can stay strong and not get tired out during long-lasting viral infections like AIDS, and it hopes to find ways to help improve treatments for people dealing with these infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10909040 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which certain T cells, specifically CD8 T cells, can resist becoming exhausted during chronic viral infections like AIDS. It focuses on the role of IL-2, a signaling molecule, produced by both CD4 and CD8 T cells, and how these signals influence T cell behavior. By studying these interactions, the research aims to improve the effectiveness of therapies that aim to rejuvenate T cell responses in patients with chronic infections. Patients may benefit from insights that could lead to better treatment strategies for managing their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with chronic viral infections, such as those with AIDS, who may benefit from enhanced immune responses.
Not a fit: Patients with acute viral infections or those who do not have chronic viral infections may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies that enhance the immune response in patients with chronic viral infections.
How similar studies have performed: Previous research has shown promising results in understanding T cell dynamics in chronic infections, suggesting that this approach has potential for success.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Zajac, Allan J — University of Alabama at Birmingham
- Study coordinator: Zajac, Allan J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.